Tag: biomedical
-
Int’l Lab Network to Assess Covid-19 Vaccines
Six clinical testing laboratories worldwide plan to evaluate vaccines for protecting against Covid-19 infections with a common set of test protocols.
-
Wireless Sensor Detects Multiple Covid-19 Indicators
Biomedical engineers designed a lab-on-a-chip sensor that quickly detects SARS-CoV-2 viruses in saliva or blood, as well as antibodies and indicators of disease severity.
-
Biotech, Analytics Companies Partner on Drug Discovery
A biotechnology company and genomics data science enterprise agreed in a multi-year agreement to discover new therapies for up to 20 diseases.
-
Group Advancing Electronic Spinal Cord Injury Therapies
A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries.
-
Study Testing Wearables Data for Covid-19 Clues
A biomedical engineering lab and analytics company are testing the feasibility of algorithms to find early signs of Covid-19 symptoms from smart watch users.
-
Mixed Early Results in Covid-19 Antibody Cocktail Trial
The developer of a synthetic antibody cocktail to treat non-hospitalized Covid-19 patients released first results from a clinical trial with some encouraging findings.
-
Start-Up Developing Thin Films for Vaccine Delivery
A new enterprise is creating thin films for vaccines, including Covid-19, to make possible their mass production and distribution at room temperatures.
-
App Tracks Public Mask Wearing for Covid-19 Evidence
A mobile app is now available for individuals to count — NOT report — people wearing face masks, as an indicator of Covid-19 community infection spread.
-
Infographic – Covid-19 Rates Rising in U.S. Kids
Children in the U.S. are now more likely to get infected from SARS-CoV-2 viruses, with their infection rates rising faster than the population at large.
-
Dexcom, UVirginia Partner on Diabetes Technology
Dexcom Inc., a maker of glucose monitoring systems, and University of Virginia are collaborating on extending the company’s current technologies to cover more types of diabetes